Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia
Loading...
Date
Authors
Miltiadous, G.
Saougos, V.
Cariolou, M.
Elisaf, M. S.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Type
Type of the conference item
Journal type
peer-reviewed
Educational material type
Conference Name
Journal name
Ann Clin Lab Sci
Book name
Book series
Book edition
Alternative title / Subtitle
Description
Familial hypercholesterolemia (FH) is characterised by elevated plasma LDL-cholesterol levels and premature ischemic heart disease. Statin therapy is mandatory in order to prevent atherosclerosis in patients with heterozygous FH. Both genetic and environmental factors affect the statin-induced LDL-cholesterol lowering effect in patients with heterozygous FH. Recently published data suggest that plasma lipoprotein(a) levels may affect the efficacy of statin therapy in patients with nephrotic syndrome. However, no data are available concerning the effect of lipoprotein(a) levels on the efficacy of statin therapy in patients with heterozygous FH. This report demonstrates negative correlation between plasma lipoprotein(a) levels and the LDL-cholesterol lowering effect of statin therapy in 49 patients with heterozygous FH.
Description
Keywords
Anticholesteremic Agents/*therapeutic use, Cholesterol, LDL/*blood, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use, Hyperlipoproteinemia Type II/blood/*drug therapy, Lipoprotein(a)/*blood, Statistics, Nonparametric
Subject classification
Citation
Link
http://www.ncbi.nlm.nih.gov/pubmed/16951279
Language
en
Publishing department/division
Advisor name
Examining committee
General Description / Additional Comments
Institution and School/Department of submitter
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής